Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study

Table 2 Analysis of factors significantly associated with adult height in females

Adult Height^a
Univariate Analysis	Correlation Coefficient		P-value
At the start of therapy
CA (yr)	-0.37		0.0348
BA (yr)	-0.38		0.0306
Peak FSH	0.35		0.0466
Growth rate	0.39		0.0336
Height SDS	0.82		<.0001
Target height	0.53		0.0019
During therapy
Averaged growth rate	0.62		0.0001
At the end of therapy
Height SDS	0.82		<.0001
Multiple Linear Regression	Beta Coefficient	P-value	R ²
Average growth rate during treatment	3.05	0.0002
Height SDS at baseline	5.11	<0.0001	0.82

^aAdult height was established when the height was associated with a growth velocity of <1 cm/year or a bone age ≥14 years in females

ISSN: 1687-9856